NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Intignus Biotech

Intignus Biotech

Private
PuneHealthcare & Life Scienceshttps://intignusbiotech.com/

Last Round

Grant

Nov 1, 2025

Total Funding Raised

$1.26M

Company Overview

Intignus Biotech is a biotechnology company that develops diagnostic devices and point-of-care tests for the early detection of pregnancy-related disorders and maternal health conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

in-vitro diagnosticIVDrapid diagnostic testmedical device manufacturingpoint-of-care testingPOCTcontract manufacturingmaternal healthmicrofluidic testclinical diagnosticsmedtechdiagnostic kitdigital health pathwaymedical device development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Intignus Biotech Comps

Public and private peers based on sector, stage, and business model.

Intignus Biotech comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Intignus Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 1, 2025
AcceleratorMar 15, 2023
VC RoundDec 20, 2022
GrantAug 20, 2020

Intignus Biotech Investors

Notable investors and investment history

Intignus Biotech investors
InvestorRounds
Biotechnology Industry Research Assistance CouncilGrant, VC Round
VillgroGrant
Department of Science & TechnologyGrant
Gates FoundationGrant
Tech4EvaAccelerator
Venture CenterVC Round
EPFL Innovation ParkAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2020

    $360K grant received from government and accelerator sources.

Intignus Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Intignus Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Intignus Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersPune
Employee Range7
Year Founded2018
Last FundingNov 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.